pimozide has been researched along with sertraline in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bomberger, JM; Deschamps, JD; Flitter, BA; Freedman, CJ; Holman, TR; Jadhav, A; Jameson, JB; Maloney, DJ; Melvin, JA; Nguyen, JV; Ogunsola, AF; Simeonov, A; Yasgar, A | 1 |
| Hollander, E; Josephson, SC; Stein, DJ | 1 |
| Buckingham, D; Gaffney, G | 1 |
| Drummer, OH; Gall, J; King, CV; McIntyre, IM; Staikos, V | 1 |
| Desta, Z; Flockhart, DA | 1 |
| Alderman, J | 1 |
| Kenchaiah, BK; Kumar, S; Tharyan, P | 1 |
| Arakawa, H; Ishii, M; Ito, MA; Mizoi, K; Morishita, H; Ogihara, T; Okawa, K; Yano, K | 1 |
| Ito, MA; Mizoi, K; Morishita, H; Ogihara, T; Perera, LMB; Yano, K; Zhang, X | 1 |
1 review(s) available for pimozide and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pimozide and sertraline
| Article | Year |
|---|---|
Coadministration of sertraline with cisapride or pimozide: an open-label, nonrandomized examination of pharmacokinetics and corrected QT intervals in healthy adult volunteers.
Topics: Adult; Cisapride; Dopamine Antagonists; Drug Interactions; Electrocardiography; Female; Humans; Male; Pimozide; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline | 2005 |
14 other study(ies) available for pimozide and sertraline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-Lipoxygenase.
Topics: Amino Acid Sequence; Animals; Antibody Formation; Arachidonate 15-Lipoxygenase; Humans; Hydroxyeicosatetraenoic Acids; Kinetics; Lipoxygenase Inhibitors; Pseudomonas aeruginosa; Rabbits; Substrate Specificity | 2016 |
Serotonin reuptake blockers for the treatment of obsessional jealousy.
Topics: 1-Naphthylamine; Adult; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Jealousy; Male; Obsessive-Compulsive Disorder; Pimozide; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
New TS treatment.
Topics: 1-Naphthylamine; Adolescent; Female; Haloperidol; Humans; Pimozide; Selective Serotonin Reuptake Inhibitors; Sertraline; Tourette Syndrome | 1993 |
A fatality involving moclobemide, sertraline, and pimozide.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antipsychotic Agents; Benzamides; Chromatography, High Pressure Liquid; Drug Interactions; Fatal Outcome; Humans; Liver; Lung; Male; Moclobemide; Pimozide; Polypharmacy; Sertraline | 1997 |
Commentary on McIntyre IM, King CV, Staikos V, Gall J, Drummer OH. A fatality involving moclobemide, sertraline and pimozide. J Forensic Sci 1997;42:951-53.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Arrhythmias, Cardiac; Benzamides; Fatal Outcome; Humans; Male; Moclobemide; Pimozide; Sertraline | 1999 |
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; Humans; Imipramine; Male; Middle Aged; Olanzapine; Pimozide; Retrospective Studies; Risperidone; Schizophrenia, Paranoid; Sertraline | 2010 |
Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein.
Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Drug Interactions; Gastrointestinal Absorption; Humans; LLC-PK1 Cells; Pimozide; Sertraline; Swine | 2020 |
P-Glycoprotein-Mediated Pharmacokinetic Interactions Increase Pimozide hERG Channel Inhibition.
Topics: Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; Humans; Male; Pimozide; Potassium Channel Blockers; Sertraline | 2022 |